Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study - Concepedia

Concepedia

Publication | Open Access

Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study

DOI Full Paper Access

38

Citations

18

References

2018

Year

Jacob A. Gordon, Carlo Buonerba, Gregory R. Pond, Daniel J. Crona, Silke Gillessen, Giuseppe Lucarelli, Sabrina Rossetti, Tanya B. Dorff, Salvatore Artale, Jennifer A. Locke,

Abstract

In this retrospective cohort, statin use was significantly associated with both prolonged OS and cancer-specific survival and increased early > 30% PSA declines. Prospective validation is warranted.

References

	Year	Citations

Page 1